PCV37 COST-EFFECTIVENESS OF ATORVASTATIN, ROSUVASTATIN, AND SIMVASTATIN IN REDUCING LDL-CHOLESTEROL TO MEET THE EUROPEAN TARGET LEVEL—BAYESIAN META-ANALYSIS AND SIMULATION Peura P1. Martikainen JA1, Hallinen T1, Soini EJ1, Niskanen L2 Unive ...
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65452-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65452-6/fulltext
Section Title :
Section Order :
611
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65452-6&doi=10.1016/S1098-3015(10)65452-6